Clinical Trial Update: Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating dexamethasone and azeliragon for post-resection cerebral edema in glioblastoma patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Azeliragon (Azeliragon)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Glioblastoma, Malignant Glioma | Phase 1 | Status: WITHDRAWN